Home Tags Qnovia

Qnovia

Qnovia, Inc., a pharmaceutical company who recently announced the clearance of its Investigational New Drug (IND) application by the U.S. Food and Drug Administration (FDA) for the RespiRx™ Nicotine Inhaler (QN-01), a prescription inhaled smoking cessation medicine, has raised $16 million in Series B funding.

Qnovia Raises $16 Mn in Series B Funding

Team SR -
© Copyright startuprise 2024 All Rights Reserved.
Exit mobile version